Thursday, 30 April 2009
AstraZeneca PLC First Quarter Results 2009
AstraZeneca has proved to be resilient in the first quarter of 2009, the result of excellent execution in driving growth in key product franchises and in all regions, whilst delivering improvements in operating efficiency. Sales in the first quarter increased by 7 percent at constant exchange rates, but were unchanged on an as reported basis as a result of the negative impact of exchange rate movements.
Download the Narrative (PDF 68kb) and the Figures (PDF 70kb) .
CONTACTS:
Media Enquiries:
Neil McCrae +44 207 304 5045 (24 hours)
Chris Sampson +44 20 7304 5130 (24 hours)
Sarah Lindgreen +44 20 7304 5033 (24 hours)
Investor Enquiries UK:
Jonathan Hunt +44 207 304 5087 mob: +44 7775 704032
Karl Hard +44 207 304 5322 mob: +44 7789 654364
Investor Enquiries US:
Ed Seage +1 302 886 4065 mob: +1 302 373 1361
Jorgen Winroth +1 212 579 0506 mob: +1 917 612 4043